Kernal is creating mRNA therapies that instruct specific cells on how to make their own drugs to cure an illness. Today, we are targeting COVID-19 and cancer, but this technique can be used for a number of other illnesses, too. With roots at MIT, Harvard and Bio Pharma, the team previously built a successful Biotech company and has deep technical expertise in mRNA space.
Sí: Kernal Biologics, Inc. tiene ahora mismo 3 vacantes abiertas en JobsRadar. 1 de ellas se abrieron en los últimos 30 días. Última actualización el 17 de septiembre de 2026 a las 17:06 UTC.